A novel pathway for presynaptic mitogen-activated kinase activation via AMPA receptors.
AMPA-type glutamate receptors play a key role in mediating postsynaptic responses of excitatory neurotransmitters. It is now well accepted that AMPA receptors are also present at the presynapse, where they are thought to modulate neurotransmitter release. However, the mechanisms through which they control synaptic vesicle traffic have remained elusive. We used cultured hippocampal neurons and growth cone particles prepared from fetal rat brain to investigate the functional role of presynaptic AMPA receptors. We show here that stimulation of presynaptic AMPA receptors induces activation of mitogen-activated protein kinase (MAPK) through a nonreceptor tyrosine kinase-dependent and Na+/Ca2+-independent mechanism. This pathway is activated predominantly in axonal growth cones compared with the somatodendritic compartment. After stimulation of presynaptic AMPA receptors, synapsin I is phosphorylated at MAPK-specific sites. These events are paralleled by a prominent increase in evoked synaptic vesicle recycling that is blocked by the specific MAPK inhibitor 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one. Similarly, in synaptosomes isolated from adult brain, AMPA stimulation induces MAPK activation and phosphorylation of synapsin I at MAPK-dependent sites and enhances significantly synaptic vesicle recycling. These results reveal a novel pathway for activation of presynaptic MAPK and suggest a role of this pathway in the regulation of short-term presynaptic plasticity.
Schenk
Ursula
U
Department of Medical Pharmacology, Consiglio Nazionale delle Ricerche, Institute of Neuroscience, Cellular and Molecular Pharmacology, Center of Excellence on Neurodegenerative Diseases, University of Milan, 20129 Milan, Italy.
Menna
Elisabetta
E
Kim
Taeyong
T
Passafaro
Maria
M
Chang
Sunghoe
S
De Camilli
Pietro
P
Matteoli
Michela
M
D000818:Animals; D002478:Cells, Cultured / Q000187:drug effects / Q000502:physiology; D003599:Cytoskeleton / Q000648:ultrastructure; D004789:Enzyme Activation / Q000187:drug effects; D005089:Exocytosis / Q000187:drug effects / Q000502:physiology; D020439:Growth Cones / Q000502:physiology; D006624:Hippocampus / Q000166:cytology / Q000196:embryology; D020935:MAP Kinase Signaling System / Q000187:drug effects; D009473:Neuronal Plasticity; D009474:Neurons / Q000737:chemistry / Q000502:physiology* / Q000648:ultrastructure; D010766:Phosphorylation; D017729:Presynaptic Terminals; D011499:Protein Processing, Post-Translational; D051381:Rats; D018091:Receptors, AMPA / Q000819:agonists / Q000502:physiology*; D017661:Receptors, Presynaptic; D013347:Subcellular Fractions / Q000378:metabolism; D016704:Synapsins / Q000378:metabolism; D013572:Synaptic Vesicles / Q000502:physiology; D013574:Synaptosomes / Q000502:physiology; D018350:alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid / Q000494:pharmacology*
D018091:Receptors, AMPA; D017661:Receptors, Presynaptic; D016704:Synapsins; D018350:alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid
Annu Rev Neurosci. 1999;22:443-85
10202545
Philos Trans R Soc Lond B Biol Sci. 1999 Feb 28;354(1381):269-79
10212475
J Neurosci. 1999 Jul 15;19(14):5861-74
10407026
J Neurosci. 1999 Aug 15;19(16):6723-32
10436029
Curr Opin Neurobiol. 1999 Oct;9(5):544-53
10508738
J Neurosci. 1999 Nov 15;19(22):9803-12
10559389
Nat Neurosci. 2000 Apr;3(4):323-9
10725920
Nat Neurosci. 2000 Apr;3(4):330-6
10725921
Nat Neurosci. 2000 Jun;3(6):551-8
10816310
Eur J Neurosci. 2000 Oct;12(10):3687-700
11029638
Nature. 2001 Mar 1;410(6824):37-40
11242034
Nat Neurosci. 2001 Aug;4(8):787-93
11477424
Nat Neurosci. 2001 Dec;4(12):1187-93
11685225
Science. 2002 Apr 19;296(5567):550-3
11910072
J Neurosci. 2002 May 1;22(9):RC220
11978861
Annu Rev Neurosci. 2002;25:103-26
12052905
J Neurosci. 2002 Jul 1;22(13):5412-22
12097493
Hippocampus. 2002;12(3):377-85
12099488
Neuron. 2002 Jul 3;35(1):135-46
12123614
J Neurosci. 2002 Nov 1;22(21):9522-9
12417676
EMBO J. 2003 Feb 3;22(3):558-68
12554656
Neuron. 2003 Apr 10;38(1):69-78
12691665
Neuron. 2003 Jun 5;38(5):773-84
12797961
Nature. 2003 Aug 7;424(6949):677-81
12904794
J Neurosci. 1992 Feb;12(2):363-75
1371312
Neuron. 2003 Oct 9;40(2):243-64
14556707
J Neurosci. 2003 Oct 15;23(28):9367-73
14561864
Nat Neurosci. 2003 Dec;6(12):1264-9
14608359
Neuron. 2003 Dec 4;40(5):945-57
14659093
Trends Cell Biol. 2004 Mar;14(3):133-40
15003622
Science. 2004 Jun 18;304(5678):1815-9
15118123
Eur J Neurosci. 2004 May;19(9):2464-74
15128400
Biol Cell. 2004 May;96(4):257-60
15145529
Neuron. 2004 Jul 22;43(2):193-205
15260956
Neuron. 2004 Jul 22;43(2):207-19
15260957
J Cell Biol. 1992 May;117(4):849-61
1577861
J Cell Biol. 1991 Mar;112(6):1215-27
1999470
J Cell Biol. 1983 May;96(5):1374-88
6404912
J Neurosci. 1984 Aug;4(8):1954-65
6470763
Cell. 1983 Dec;35(2 Pt 1):573-84
6652678
J Biol Chem. 1995 Sep 29;270(39):22783-7
7559406
Cell Motil Cytoskeleton. 1995;30(3):194-207
7758136
J Cell Biol. 1994 Sep;126(6):1527-36
8089183
Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3679-83
8622996
J Biol Chem. 1996 Aug 30;271(35):21108-13
8702879
Trends Neurosci. 1996 May;19(5):163-71
8723198
Brain Res Dev Brain Res. 1996 Oct 23;96(1-2):83-96
8922671
J Neurosci. 1997 Jun 15;17(12):4672-87
9169528
Nature. 1997 Oct 2;389(6650):502-4
9333240
Nature. 1999 Jan 7;397(6714):72-6
9892356